Skip to content
zameds

Phentermine (Inocrave, Duromine)

Phentermine

Inova Pharmaceuticals (Pty) Ltd

S5

Registration

Applicant
Inova Pharmaceuticals (Pty) Ltd
Registrations
4
Schedule source
Consolidated Schedules 06 July 2026

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Inocrave 15

EACH CAPSULE CONTAINS PHENTERMINE 15,0 mg

1555089155/11.3/0891RegisteredS5None
Inocrave 30

EACH CAPSULE CONTAINS PHENTERMINE 30,0 mg

3055089255/11.3/0892RegisteredS5None
Duromine 15

EACH CAPSULE CONTAINS PHENTERMINE A 15,0 mg

15B0657Old MedicineS5None
Duromine 30

EACH CAPSULE CONTAINS PHENTERMINE A 30,0 mg

30B0658Old MedicineS5None

Regulatory status

Where S5 sits on the scale

Prescription-only, with tighter controls on repeats.

Schedule 5 medicines need a prescription, and repeat dispensing is capped at six months in total; the prescriber must state upfront how many times, and at what intervals, it may be repeated. Extra limits apply to some uses: if it is being used for its anxiolytic, antidepressant, tranquillising or analgesic properties, it cannot be prescribed for longer than six months without a further consultation. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.

Schedule S5, matched to the Consolidated Schedules by ingredient, confidence high.

Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it.

Consolidated Schedules listings for Phentermine

  • S5: Phentermine

    Consolidated Schedules 06 July 2026, line 9641

Pharmacological class: Anorexigenics. (class 11.3)

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

C10H15N149.23 g/mol

2-Methyl-1-phenylpropan-2-amine

Drag to rotate. Structure from PubChem CID 4771.

SAHPRA documents

SAHPRA has not published a professional information or patient information leaflet for this product.

Background

Loading...
Loading Wikipedia summary

Research articles

Loading...
Loading PubMed articles